Evidence map›Paper›PMID 37608221›Full record

ArticleJournal of neurology2023

Susac syndrome: neurological update (clinical features, long-term observational follow-up and management of sixteen patients).

Smriti Bose, Athanasios Papathanasiou, Sameep Karkhanis, Jason P Appleton, Dominic King, Ruchika Batra, Susan P Mollan, Saiju Jacob

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06349603 (Integrated Physiotherapy Approach for Susac Syndrome), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06349603 completednot on this map

Integrated Physiotherapy Approach for Susac Syndrome: A Comprehensive Case Study

TypeobservationalSponsorRehabilitation Centre ZivotRan2023 to 2023Enrolled1ConditionsSusac Syndrome
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Susac syndrome - different treatment approaches for one disease (analysis of case series).Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Smriti Bose *Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Athanasios Papathanasiou *Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Sameep Karkhanis *Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Jason P AppletonDepartment of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Dominic KingDepartment of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Ruchika BatraDepartment of Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Susan P MollanDepartment of Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Saiju JacobDepartment of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK. saiju.jacob@uhb.nhs.uk.ORCID http://orcid.org/0000-0003-0037-454X
University Hospitals Birmingham NHS Foundation Trust · GBNottingham University Hospitals NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Susac syndrome is a likely autoimmune microangiopathy affecting the brain, retina and inner ear. Due to the rarity of this condition, diagnosis and treatment can be challenging. Diagnosis is based on the presence of the clinical triad of central nervous system dysfunction, branch retinal artery occlusions and sensorineural hearing loss. Typical MRI findings of callosal and peri-callosal lesions may assist in diagnosis. Clinical course can be monophasic, polycyclic or chronic continuous. It is important to look out for red flags to attain an accurate diagnosis and follow a therapeutic algorithm based on severity of the disease and response to treatment. Patients are treated with steroids and immunosuppressive agents with a variable response. Early aggressive treatment especially in severe cases, may help in preventing relapses and morbidity/disability. This study highlights important diagnostic features and proposes a treatment algorithm based on clinical experience from management of 16 patients from 2 neuroscience centres in the UK since 2007, who were followed up over a long period of 3-15 years.

Indexed as

Retinal Artery OcclusionSusac SyndromeBrainFollow-Up StudiesHumansMagnetic Resonance ImagingBranch retinal artery occlusionEncephalopathySensorineural hearing lossSusac syndromeVisual loss

Identifiers

PMID37608221
PMCPMC10632257
OpenAlexW4386072621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.